Race Oncology Limited (ASX:RAC)
Australia · Delayed Price · Currency is AUD 2.860
-0.060 (-2.05%)
Dec 4, 2025, 3:59 PM AEST
Race Oncology Market Cap
Race Oncology has a market cap or net worth of 518.03 million as of December 3, 2025. Its market cap has increased by 112.50% in one year.
Market Cap
518.03M
Enterprise Value
504.36M
Revenue
6.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.86
Market Cap Chart
Since July 13, 2016, Race Oncology's market cap has increased from 12.64M to 518.03M, an increase of 3,999.24%. That is a compound annual growth rate of 48.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 518.03M | 120.90% |
| Dec 31, 2024 | 234.51M | 70.76% |
| Dec 29, 2023 | 137.34M | -57.61% |
| Dec 30, 2022 | 324.00M | -43.55% |
| Dec 31, 2021 | 574.00M | 153.36% |
| Dec 31, 2020 | 226.55M | 992.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 88.56B |
| Pro Medicus | 27.16B |
| Cochlear | 18.03B |
| Sonic Healthcare | 11.65B |
| Ramsay Health Care | 8.64B |
| Ansell | 5.20B |
| Telix Pharmaceuticals | 4.89B |
| Mesoblast | 3.31B |